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Letters
COMMENT&RESPONSE
Hospitalization for Pneumonia
and Risk of Cardiovascular Disease
To the Editor The study by Dr Corrales-Medina and
colleagues1 showed that hospitalization for pneumonia was
associated with enhanced short-term and long-term risks of
cardiovascular disease (CVD), including myocardial infarc-
tion, stroke, and fatal coronary artery disease. There are
several methodological and clinical issues that need to be
addressed to further examine the association between
pneumonia and CVD.
Although the authors correctly excluded statin use from
the analysis, the concomitant use of aspirin was not consid-
ered as a potentially confounding factor. Because cases and
controls in both cohorts had atherosclerotic risk factors such
as hypertension, diabetes, and dyslipidemia, these patients
may have been taking aspirin. An observational study2 per-
formed in 1005 patients with pneumonia demonstrated that
at 30 days, long-term aspirin use was associated with lower
mortality and nonfatal CVD.
Theauthors included2cohortswithdifferences inage.The
meanage intheCardiovascularHealthStudy(CHS)was73years
and themean age in the Atherosclerosis Risk in Communities
(ARIC) studywas55years. The riskofCVDwasassociatedwith
agebecauseat 30days fromadmission,CVDoccurred in 10.6%
of the older population compared with 0.9% of the younger
population. This finding is consistent with our study show-
ing an 11% incidence ofmyocardial infarction during the hos-
pital stay in a cohort with a mean age of 70 years affected by
pneumonia.3
In addition to age, another factor that increases the risk
ofCVD is the severityofpneumonia. Previous reports fromthe
same authors and our group3,4 showed that pneumonia se-
verity score was independently associated with CVD. There
is a discrepancy between these previous findings and the
present study that showed no association between pneumo-
nia severity and CVD risk.
Based on these considerations, we believe that older pa-
tients with severe pneumonia should be primarily consid-
ered for CVDprevention and that randomized clinical trials to
assess approaches to reduce the risk of CVD in patients with
pneumonia are warranted.
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In Reply Dr Violi and colleagues raise the possibility that an
association between hospitalization for pneumonia and
subsequent increase in CVD risk may be confounded by dif-
ferential use of aspirin prior to the occurrence of pneumo-
nia. We did not include aspirin usage because it was missing
in 11% to 40% of participants at various time points during
the first 10 years of follow-up in the CHS. The Table shows
Table. Frequency of Aspirin Use Prior to Pneumonia in the Cardiovascular Health Study
Previous Aspirin Use, No./Total (%)a
P ValuePneumonia Cases Controls
Primary analysisb
Participants but not controls hospitalized for pneumonia 405/591 (68.5) 818/1182 (69.2) .77
Sensitivity analysesb
Participants hospitalized for pneumonia and controls
hospitalized for other reasons
422/614 (68.7) 422/614 (68.7) >.99
Participants but not controls hospitalized for pneumonia
(primary discharge diagnosis for participants)
264/379 (69.7) 518/758 (68.3) .65
Participants but not controls hospitalized for pneumonia
(no concomitant diagnosis of heart failure
during hospitalization)
351/516 (68.0) 708/1032 (68.6) .81
a Aspirin use was collected annually
for the first 10 years and calculated
using either data collected at
baseline or at the last available time
point prior to pneumonia
hospitalization.
b Primary and sensitivity analyses as
outlined in themain study.
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aspirin use based on data collected at baseline and at addi-
tional time points prior to hospitalization for pneumonia if
these data were available. Aspirin use was similar between
the 2 groups, suggesting that confounding by unaccounted
aspirin use is unlikely.
We agree with the authors that advanced age is an
important risk factor for CVD after pneumonia. This is sup-
ported by the substantial difference in incident CVD after
hospitalization for pneumonia between the 2 cohorts that
we analyzed (CHS: mean age of 73 years and 10-year risk of
35% for CVD vs ARIC study: mean age of 55 years and
10-year risk of 16.5% for CVD). In regard to their point about
the severity of pneumonia being an important risk factor for
subsequent CVD, we also agree that previous studies sup-
port this concept. However, our study was not designed to
address this question. Instead, we chose to perform a strati-
fied analysis by pneumonia severity to determine whether
the association between hospitalization for this infection
and increased risk of CVD was present in cases of both
severe and nonsevere pneumonia.
WeagreewithVioli and colleagues that randomized clini-
cal trials of interventions to reduce CVD after hospitalization
for pneumonia are needed, and that older adults with severe
pneumonia would be a high-risk group in which these inter-
ventions could demonstrate benefit.
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Sedation Protocol for Critically Ill Pediatric Patients
To the Editor In the Randomized Evaluation of Sedation Titra-
tion for Respiratory Failure (RESTORE) trial, Dr Curley and
colleagues1 found that anurse-implemented, goal-directed se-
dation protocol for children undergoing mechanical ventila-
tion for acute respiratory failure did not reduce the duration
ofmechanical ventilation comparedwith standard of care. In
an accompanying Editorial, Dr Mehta2 raised the question of
whether a low adherence rate to a complex protocol (71%-
100%) or a difference in administered drugswith bioaccumu-
lationbetweenthegroupscontributed to thenull findings.This
large randomized clinical trial of sedationusing abedsidepro-
tocol in critically ill childrenmayhavebeen confoundedbyan
intervention group who were younger and less sick and who
received more frequent assessments.
Previous work in adult critical care has demonstrated 3
fewer days of mechanical ventilation through the use of a
multidisciplinary team bundle approach to care based on an
ABCDE (awakening and breathing coordination, delirium
monitoring/management, and early exercise/mobility)
protocol.3 This approach has allowed patients to be more
awake to participate in early mobility and physical therapy,
potentially minimizing myopathy acquired in the intensive
care unit and reducing time spent receiving mechanical
ventilation.
Previouswork by Curley et al4 has demonstrated that the
State Behavioral Scale (SBS) has an interrater reliability score
of 0.44 to0.76 in younger patients. I questionwhether the au-
thors’null findingsmayresult fromthevariationbetweenbed-
side nurses or between different centers because the unit of
randomization was the pediatric intensive care unit (PICU).
Were measures of variation between bedside nurses deter-
mined prior to the study? Was consideration given to addi-
tional measurements for level of sedation prior to the study?
Also, could a high turnover of PICU nurses have led to a rela-
tively inexperienced workforce responsible for sedation as-
sessments? Do the authors have any further data thatmay of-
fer insight into how turnover or experience may have
confounded the study?
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In Reply Dr Remy is concerned that null findings of the
RESTORE clinical trial may have been the result of the clus-
ter randomized design leading to variation in sedation
assessments between bedside nurses and among different
centers. Remy asks whether measures of variation between
bedside nurses were determined prior to the study, whether
additional sedation measures were considered, and whether
nurse turnover or experience could have confounded study
results.
During the RESTORE start-up phase, all PICUs imple-
mented the SBS as a unit-based standard of care. The SBS was
selected because it was the only valid and reliable sedation
assessment instrument specific for intubated pediatric
patients. The weighted κ scores of 0.44 to 0.76 noted by
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